BALTIMORE, MD, January 13, 2025 – A groundbreaking new study in the INFORMS journal Transportation Science reveals the severe and far-reaching consequences of Russia’s full-scale invasion of Ukraine on global food security. The research highlights an urgent need to address disruptions in the transportation of Ukrainian grains, which have caused dramatic price spikes and worsened food insecurity worldwide, particularly in vulnerable regions such as the Middle East and North Africa.
Cutting-edge chips, especially those designed to power emerging AI applications, tend to receive the most attention in the media and generate the most excitement. However, so-called “legacy” chips are just as important — if not more — to our daily lives.
January is National Blood Donor Month and, not coincidentally, a time when donations tend to ebb. Every two seconds, someone in the U.S. needs blood for serious injuries, childbirth, cancer treatments and more, according to the Department of Health and Human Services.
An audio journey of how data and analytics save lives, save money and solve problems.
Ashley Smith
Public Affairs Coordinator
INFORMS
Catonsville, MD
[email protected]
443-757-3578
Explore our resources for multiple topics including:
Yuri Levin, professor of Queen’s University Smith School of Business specializing in business analytics and artificial intelligence, takes up the position of Dean of Moscow School of Management SKOLKOVO.
Julie Swann, a professor of industrial and systems engineering at North Carolina State University, who advised the CDC during the H1N1 response, said she believes North Carolina will have all of the necessary logistics in place for mass distribution of a coronavirus vaccine as soon as one if approved.
The U.S. just reached a dark milestone: 10 million reported coronavirus cases. But there is also big news for a potential coronavirus vaccine. On November 9, Pfizer and German drugmaker BioNTech announced that data from their ongoing coronavirus vaccine trial shows the vaccine is more than 90% effective in preventing COVID-19, per the New York Times.
The duo's vaccine, known as BNT162b2, proved to be 90% effective after being tested on nearly 44,000 participants in its Phase III study. This is a significant milestone in the fight against a virus that has infected more than 50 million people around the globe, resulting in over 1.2 million deaths. FOX Business takes a look at the key data points investors and consumers should know, as well as reactions from business and political leaders.
Prashant Yadav of the Center for Global Development and Tinglong Dai of Johns Hopkins University, join “Squawk on the Street” to discuss coronavirus vaccine development and distribution.
OR/MS Today is the INFORMS member magazine that shares the latest research and best practices in operations research, analytics and the management sciences.
Access OR/MS Today Magazine
Analytics magazine showcases articles and research reports based on big data, AI, machine learning, data analytics and other new-age technologies.
Access Analytics Magazine